Overexpression of CD45RO+ among TILs has been associated with improved outcomes in various cancers as well as NSCLC [91] while high infiltration of FOXP3+ Tregs has been correlated with poor survival in NSCLC [92]. The gene discussed is FOXP3; the disease is non-small cell lung carcinoma.